FDA Inspection 1063269 — Everest Life Sciences LLC
The FDA completed an inspection of Everest Life Sciences LLC on Jul 13, 2018 in Plainsboro, NJ. The inspection was classified NAI (No Action Indicated — no objectionable conditions or practices were found during the inspection). Product area: Drugs.
Inspection details
- Classification
- No Action Indicated (NAI)
- End Date
- Jul 13, 2018
- Fiscal Year
- 2018
- Product Type
- Drugs
- Project Area
- Drug Quality Assurance
- Location
- Plainsboro, NJ (United States)